SCHEMBL1807745

SCHEMBL1807745

CCOC(=O)c1c(C)n[nH]c1-c1ncccc1Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.50
TDP2 O95551 3/20 0.42
ALDH1A1 P00352 3/20 0.42
POLB P06746 1/20 0.42
ADORA3 P0DMS8 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
HTT P42858 2/20 0.40
MAPK10 P53779 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
IDO1 P14902 1/20 0.39
BRD4 O60885 1/20 0.39
RAB9A P51151 2/20 0.39
PTGES O14684 1/20 0.39
ALOX5 P09917 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1806318 0.85 PDE4D (0.50) PDE4DTDP2ALDH1A1POLBADORA3
SCHEMBL1807009 0.83 PDE4D (0.48) PDE4DTDP2ALDH1A1POLBADORA3
SCHEMBL1806748 0.82 PDE4D (0.47) PDE4DTDP2ALDH1A1POLBADORA3
SCHEMBL1805935 0.81 PDE4D (0.46) PDE4DTDP2ALDH1A1POLBADORA3
SCHEMBL1809756 0.81 PDE4D (0.46) PDE4DTDP2ALDH1A1POLBADORA3
SCHEMBL1808198 0.79 PDE4D (0.43) PDE4DTDP2ALDH1A1POLBADORA3
SCHEMBL1807386 0.79 PDE4D (0.43) PDE4DTDP2ALDH1A1POLBADORA3
SCHEMBL1806943 0.75 TDP2 (0.43) PDE4DTDP2ALDH1A1POLBSMN1; SMN2
SCHEMBL19209480 0.75 PDE4D (0.59) PDE4DALDH1A1ADORA3SMN1; SMN2HTT
SCHEMBL1807759 0.72 TDP2 (0.42) PDE4DTDP2ALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501703-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060035-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed